FindTrial
Sign In

An observational, single-center, pilot study comparing the regression of sensory block between 0.75% ropivacaine heavy and 0.5% bupivacaine heavy following spinal anesthesia in pregnant women undergoing cesarean section.

Prospective, comparative, observational, single centre, pilot study to compare regression of sensory block of 0.75 % ropivacaine heavy with 0.5% bupivacaine heavy after subarachnoid block in pregnant patients coming for caesarean section. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/01/078912
Enrollment
24
Registered
2025-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Bhaktivedanta Hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Parturient age group: 18-35. ASA status: I and II. Uncomplicated singleton pregnancy.

Exclusion criteria

Exclusion criteria: Patients unwilling to participate in the study. ASA statues: greater than II. Parturients with comorbidities like pregnancy induced hypertension and cardiovascular diseases. Patients with altered consciousness, significant neurological, psychiatric, neuromuscular, cardiovascular diseases. Morbid obesity [Body mass index (BMI)greater than 40 kg/m2] Obstetrical complications like Antepartum Haemorrhage, Pregnancy induced hypertension, raised intracranial pressure. Contraindications to spinal anaesthesia like deformities of spine, Neurological disorders, Skin infections.

Design outcomes

Primary

MeasureTime frame
To compare the level of sensory blockade between 0.5% bupivacaine heavy and 0.75% ropivacaine heavy and To assess sensory level regressionTimepoint: Post administration of subarachnoid block: At 90 seconds, 30 minutes, and 40 minutes—

Secondary

MeasureTime frame
1)To compare the percentage fall in blood pressure 2)To compare the percentage change in heart rate 3)To compare the level of motor blockade at 40 minutes post subarachnoid block between 0.5% bupivacaine heavy and 0.75% ropivacaine heavyTimepoint: 1) To compare the percentage fall in blood pressure at: 90 seconds and 5 minutes post subarachnoid block between 0.5% bupivacaine heavy and 0.75% ropivacaine heavy.2) To compare the percentage change in heart rate at: 90 seconds and 5 minutes post subarachnoid block between 0.5% bupivacaine heavy and 0.75% ropivacaine heavy. 3) To compare the level of motor blockade at 40 minutes post subarachnoid block between 0.5% bupivacaine heavy and 0.75% ropivacaine heavy.—

Countries

India

Contacts

Public ContactDr Shilpa Tiwaskar

Bhaktivedanta Hospital and Research Institute

drtiwaskar@gmail.com9820067137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026